Biotech CEO
Walk into the next round with the story already written.
You don't have a market access department. You have a CMO, a CFO and twelve weeks until the data readout. Knowledgeable gives you the value story, the competitive map and the BD-ready narrative one strategic hire would have taken eighteen months and a million dollars to build.
"Build the Series C value story for our Phase 2 oncology asset, with the most likely acquirer's lens applied."
The work that finally lands the way you scoped it.
An investor-grade narrative, not a deck
Mechanism, competitive position, unmet need, payer pathway, written in the language your next investor or acquirer actually evaluates against.
BD diligence pre-answered
The 200-question due-diligence list every pharma BD team sends, with grounded, source-linked answers ready before the call.
Competitive landscape that updates itself
Competitor readouts, label moves and class effects monitored continuously. You hear about it before your board does.
One operator, the output of eight
Your Head of Strategy ships market access, HEOR, BD support and investor narrative, without hiring the team to do it.
Make the next round the easiest one you've raised.
Show me biotech leverageDiligence-ready from day one.
Every claim source-linked, every export auditable. Designed to align with the EU AI Act, SSO + MFA, EU/UK residency, the things every acquirer's InfoSec team will ask about before they touch your data room.